Home › Compare › CRPOF vs EQR

CRPOF vs EQR: Dividend Comparison 2026

CRPOF yields 1176.47% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CRPOF wins by $78814195.15M in total portfolio value
10 years
CRPOF
CRPOF
● Live price
1176.47%
Share price
$0.17
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78814195.20M
Annual income
$67,523,701,253,088.38
Full CRPOF calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — CRPOF vs EQR

📍 CRPOF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCRPOFEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CRPOF + EQR cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CRPOF pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CRPOF
Annual income on $10K today (after 15% tax)
$100,000.00/yr
After 10yr DRIP, annual income (after tax)
$57,395,146,065,125.13/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, CRPOF beats the other by $57,395,146,060,470.86/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CRPOF + EQR for your $10,000?

CRPOF: 50%EQR: 50%
100% EQR50/50100% CRPOF
Portfolio after 10yr
$39407097.62M
Annual income
$33,761,850,629,281.99/yr
Blended yield
85.67%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

CRPOF
No analyst data
Altman Z
3.3
Piotroski
2/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CRPOF buys
0
EQR buys
0
No recent congressional trades found for CRPOF or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCRPOFEQR
Forward yield1176.47% ✓5.87%
Annual dividend / share$2.00$3.47 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$78814195.20M ✓$47.8K
Annual income after 10y$67,523,701,253,088.38 ✓$5,475.61
Total dividends collected$77969765.27M ✓$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: CRPOF vs EQR ($10,000, DRIP)

YearCRPOF PortfolioCRPOF Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$128,347$117,647.06$11,380$679.82+$117.0K → CRPOF
2$1,548,514$1,411,182.61$13,014$837.25+$1.54M → CRPOF
3$17,569,052$15,912,142.01$14,961$1,036.20+$17.55M → CRPOF
4$187,523,354$168,724,468.35$17,297$1,289.22+$187.51M → CRPOF
5$1,883,716,681$1,683,066,692.55$20,121$1,613.15+$1883.70M → CRPOF
6$17,816,329,317$15,800,752,468.33$23,561$2,030.84+$17816.31M → CRPOF
7$158,731,384,105$139,667,911,735.60$27,783$2,573.54+$158731.36M → CRPOF
8$1,332,782,916,056$1,162,940,335,063.89$33,013$3,284.39+$1332782.88M → CRPOF
9$10,551,863,503,163$9,125,785,782,982.70$39,547$4,223.51+$10551863.46M → CRPOF
10$78,814,195,201,473$67,523,701,253,088.38$47,791$5,475.61+$78814195.15M → CRPOF

CRPOF vs EQR: Complete Analysis 2026

CRPOF — Stock

Ceapro Inc., a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. It operates in two segments, Active Ingredient Product Technology Industry and Cosmeceutical Industry. The Active Ingredient Product Technology Industry segment develops proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries. The Cosmeceutical Industry segment is involved in the development and commercialization of anti-aging products derived from natural active ingredients sold directly to the end-user primarily through online website sales and through select natural products stores. The company was incorporated in 1997 and is headquartered in Edmonton, Canada.

Full CRPOF Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this CRPOF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CRPOF vs SCHDCRPOF vs JEPICRPOF vs OCRPOF vs KOCRPOF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.